GLP-1 medications dont target belly fat specifically, but they can support overall fat loss (including visceral fat) by helping appetite control and calorie adherence
To learn more, see the Boxed warning for semaglutide section
[2] Additionally, GLP-1 agonists may be prescribed for individuals with type 2 diabetes who have coexisting conditions such as atherosclerosis, heart failure, or chronic kidney disease, as these medications have demonstrated potential benefits beyond glycemic control
/
Which brand is best for weight loss
However, after we added a bacterial-type selenocysteine insertion sequence element to the open reading frame we successfully expressed TGR, using the strategy previously employed for production of mammalian TrxR [14,15]